If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 4 Dec: Fierce optimism despite challenging circumstances
• 3 Dec: Quantifying 25 years of malaria control impact in Africa
• 9 Dec: Strengthening malaria control through better ITN surveillance
• 11 Dec: Making Medicines Easier to Take: XTEMP-R Benefits More than Children with TB
• 19 Dec: TB Alliance and Asian Development Bank Forge Strategic Partnership to Strengthen Regional Efforts Against Tuberculosis
• 12 Dec: Staying the course in 2025
• 19 Dec: The appeal of a dual-parasite combination vaccine
• 19 Dec: The future looks bright for malaria prevention
• 6 Jan: MMV and Noguchi Memorial Institute partner to accelerate antimalarial drug discovery
• 4 Dec: WHO launches the 2025 World Malaria Report as pressure from drug resistance grows
• 9 Dec: Opinion: 3 ways AI can support drug innovation and global research equity
• 15 Dec: Co-creating an innovative AI platform to advance global health research
• 4 Dec: Dr Javid Abdelmoneim, Datuk Dr Mahathar bin Abd Wahab, Dr Taruna Madan, Violet Naanyu, and Dr Mario Santos Moreira join the Board of Directors at DNDi
• 8 Dec: DNDi statement on COP30: Advancing health in the climate agenda
• 16 Dec: DNDi 2025 in Review: A message from DNDi Executive Director Dr Luis Pizarro
• 3 Dec: IVI and the Regionalized Vaccine Manufacturing Collaborative sign partnership agreement to advance regional vaccine manufacturing and equity
• 9 Dec: Scientists in Korea to create mRNA vaccine against emerging tick-borne virus in Asia
• 8 Dec: Placental Malaria remains a major threat to mothers and newborns, new EVI study shows
• 10 Dec: Proving the value of malaria vaccines: how case-control studies can guide immunisation strategies
MDGH
PDP Funder News/Announcements
• 1 Dec: Lenacapavir use kicks off in South Africa and Brazil through Unitaid partnership with Wits RHI and Fiocruz. Unitaid
• 3 Dec: With Child Deaths Projected to Rise for the First Time This Century, Gates Foundation Urges Global Leaders to Target Scarce Resources Where They Save the Most Lives. Gates Foundation
• 9 Jan: From innovation to impact: Reflections from Dr. Philippe Duneton on 20 years of Unitaid. Unitaid
• 12 Jan: Gates Foundation Appoints New Members to Governing Board, Executive Leadership Team and Elevates Role of African and India Offices. Gates Foundation
• 13 Jan: Wellcome Annual Report 2025. Wellcome
• 13 Jan: Unitaid approves new investments to accelerate equitable access to lenacapavir for HIV prevention. Unitaid
• 14 Jan: Gates Foundation Commits to Historic $9 Billion Annual Payout, Strengthens Stewardship to Maximize Mission Impact Through Closure in 2045. Gates Foundation
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• 7 Jan: Transforming the Global Health Ecosystem: Lessons Learned and a Vision for the Future. Accra Reset
• 16 Jan: The Gates effect: private foundations and donor funding shifts in global health. UNU
Related Press Releases/ Announcements/Articles
• 1 Jan: “Future vaccine innovation will be integration of R&D, regulatory support and manufacturing”. BioSpectrum India
• 1 Dec: Money Matters: New data on the world’s biggest development philanthropies. Devex
• 1 Dec: Africa is Stuck Between Global Pathogen-Sharing Talks and Conflicting US Bilateral Agreements. Health Policy Watch
• 1 Dec: Progress In Fight Against Malaria, As New Treatment Shows Promise. Forbes
• 1 Dec: 10 groundbreaking advances that grew out of HIV research. Duke University
• 1 Dec: New prevention tools and investment in services essential in the fight against AIDS. WHO
• 1 Dec: How vaccines – and yoghurt – could reduce colonisation with antibiotic-resistant bugs. Gavi
• 1 Dec: Medicines for All Institute develops low-cost process to make HIV-prevention medication. VCU News
• 1 Dec: Spillover in dengue trials. The Lancet Infectious Diseases
• 1 Dec: Spillover in dengue trials – Author's reply. The Lancet Infectious Diseases
• 1 Dec: SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch. Bhekisisa
• 1 Dec: Aid cuts have shaken HIV/Aids care to its core – and will mean millions more infections ahead. The Guardian
• 1 Dec: Treatment and prevention of HIV/AIDS: Unfinished business. PLOS Medicine
• 1 Dec: Lenacapavir Can Transform HIV Prevention—If Countries Support Access. Think Global Health
• 1 Dec: Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet HIV
• 2 Jan: A One Health trial design to accelerate Lassa fever vaccines. Nature
• 2 Dec: Strengthening nationally led approaches to new product introduction for HIV prevention. The Lancet HIV
• 2 Dec: Aligning drug prices and innovation: How global spillovers shape the future of medicines. Vox EU
• 2 Dec: Snare of Bilateral Deals Hangs Over The Multilateral Effort On The Pathogen Access & Benefit Sharing System. Geneva Health Files
• 2 Dec: ‘Creeping catastrophe’: Climate change is driving global rise in infectious diseases, leading health experts warn. Centre for Tropical Medicine and Global Health
• 2 Dec: SA’s first batch of LEN jabs will arrive in February. Use our dashboard to find out who should get them. Bhekisisa
• 3 Jan: The Future of mRNA Is Being Built in APAC. BioSpectrum Asia
• 3 Dec: Congo hosts Africa’s first simulation exercise on antimicrobial resistance surveillance. WHO AFRO
• 3 Dec: Africa sets course for affordable, quality medicines with new 10-year roadmap. WHO AFRO
• 4 Dec: Global Malaria Threat Deepens as Drug Resistance Rises. Health Policy Watch
• 4 Dec: New tools saved a million lives from malaria last year but progress under threat as drug resistance rises. WHO
• 4 Dec: 200,000 children under the age of 5 to die this year because of foreign aid cuts. The Independent
• 4 Dec: Source of Lenacapavir for PrEP Supply to Early Adopter Countries. AVAC
• 4 Dec: Battle against malaria has stalled, WHO warns. The Telegraph
• 4 Dec: Reimagining global health architecture: the way forward to ensure global health security. The Lancet
• 4 Dec: Health data science revolution in Africa: potential for addressing the myriad health challenges. Nature
• 4 Dec: Zambia rolls out the malaria vaccine – and not a moment too soon. Gavi
• 4 Dec: Beyond Thimerosal: Preserving Vaccine Access Amid Growing Hesitation. Think Global Health
• 4 Dec: A new era dawns for Gavi, as Board underlines strategic shift towards country ownership and increased support for the most vulnerable. Gavi
• 4 Dec: Single-dose dengue vaccine ‘will help Amazon communities’. Gavi
• 4 Dec: Long-acting HIV treatment could improve outcomes for breastfeeding women. News Medical
• 4 Dec: FDA to lower number of trials required for approval of drugs, other medical products. STAT
• 4 Dec: Korea steps up pandemic response with $18.9m investment in CEPI. CEPI
• 4 Dec: US Signs pact with Kenya under America First global health plan. Reuters
• 4 Dec: Pathogens, Power and the Price of Aid: Why Africa Must Stand United. Global Policy Journal
• 5 Jan: Why the approval of two new gonorrhoea treatments is a game changer. BMJ
• 5 Jan: What are the biggest vaccine breakthroughs coming in 2026? We asked five experts. Gavi
• 5 Jan: Malaria prevention in children and pregnant women: a review of gaps and emerging challenges in sub-Saharan Africa. Nature
• 5 Jan: HIV prevention for young African women is about choice. The Lancet
• 5 Jan: Due south: navigating volatile health research landscapes. The Lancet
• 5 Jan: Uptake of dapivirine vaginal ring and oral pre-exposure prophylaxis among women accessing HIV prevention services in South Africa: a cohort study. The Lancet
• 5 Jan: Strengthening nationally led approaches to new product introduction for HIV prevention. The Lancet
• 6 Jan: Mpox antibodies wane 2 years after infection or vaccination, study finds. CIDRAP
• 6 Jan: What Are The Actual Impacts Of The 2025 Cuts To Global Health Aid? A Narrative Review. Geneva Health Files
• 6 Jan: Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial. Nature
• 6 Jan: Francois Nosten on Fever Pitch podcast, on a collapsing border where medicine meets war. Centre for Tropical Medicine and Global Health
• 6 Jan: What the Development Finance Corporation Reauthorization Means for Global Health Security. Think Global Health
• 6 Jan: How Big Should a Pull Incentive Be? A New Pull Incentive Sizing Tool to Foster Innovation. CGD
• 7 Jan: Transforming the Global Health Ecosystem for a Healthier World in 2026. Think Global Health
• 7 Jan: Controversial US-Backed Vaccination Study Begins in Guinea-Bissau. Health Policy Watch
• 7 Jan: Superbug fears as new drug-resistant strains of typhoid emerge in Asia. The Telegraph
• 7 Jan: GSK's 'functional cure' for hep B proves worth in Phase 3 trials setting up approval push. Fierce Biotech
• 7 Jan: Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication. Fierce Biotech
• 8 Jan: Ambitious research aims to develop multivalent vaccines to protect against multiple deadly filoviruses. CEPI
• 8 Jan: Emerging Problems, Emerging Solutions, Emerging Voices. International Health Policy
• 8 Jan: 3 key global health leadership changes to watch. Devex
• 8 Jan: EXCLUSIVE: Germany to Halve Funding for Pandemic Hub Amid Global Health Pull-back. Health Policy Watch
• 8 Jan: Unlocking potential: Development finance reforms needed to support localized health product manufacturing. PLOS
• 8 Jan: Will mpox go global again? Research shows it's evolving in curious ways. Nature
• 8 Jan: The effectiveness of long-lasting spatial repellent emanators against malaria in humanitarian crisis settings in northern Nigeria: a two-arm pragmatic, open-label, controlled trial. The Lancet
• 9 Dec: How the Foundation is driving real progress toward global health equity. Access to Medicines Foundation
• 9 Jan: Emergent BioSolutions, PANTHER Partner to Advance Africa CDC-Led MpOx Study. Africa CDC
• 9 Jan: Global health is in crisis: to reach neglected patients, we need to reimagine medical research. BMJ
• 9 Jan: December Deals: US Signs Bilateral Health Agreements with 14 African Countries – With Some Key Exceptions. Health Policy Watch
• 9 Jan: “It doesn’t require blood!”: Perceptions around non-invasive malaria testing tools in Indonesia, Peru, and Rwanda. PLOS One
• 10 Dec: Top funders for malaria-related research and development globally. The Star
• 10 Dec: Mosquitoes outsmarting sprays, WHO report shows. Daily Nation
• 10 Dec: The fight to beat neglected tropical diseases was going well. 2025 could change that. NPR
• 10 Jan: The urgent need for African research collaboration on medicine quality. Nature
• 10 Jan: Zoliflodacin shows benefit as an oral treatment for uncomplicated gonorrhoea. The Lancet
• 10 Jan: Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial. The Lancet
• 10 Jan: Copper for HIV drugs: Inside Trump’s new aid trade. The Telegraph
• 10 Dec: Sinergium paves the way for Latin American mRNA vaccines with new preclinical study. CEPI
• 10 Dec: UNAIDS calls on African leaders to resource the HIV response, protect human rights, and seize the opportunity of new innovations to end AIDS. UNAIDS
• 11 Dec: Track the Science; Advance the Priorities: The 2025 Update of the People’s Research Agenda. AVAC
• 11 Dec: When politics Trumps science: Why the US isn’t giving SA LEN. Bhekisisa
• 11 Dec: Molecular epidemiology of Plasmodium falciparum drug resistance and vaccine targets in high-transmission settings in Africa. Nature
• 11 Dec: From promise to programs—How to ensure PrEP science is translated into global impact. Positively Aware
• 11 Dec: Zoliflodacin shows benefit as an oral treatment for uncomplicated gonorrhoea. The Lancet
• 11 Dec: New antibiotic can effectively treat gonorrhea, study finds. STAT
• 11 Dec: Global tuberculosis response off track: urgent priorities to end the world's top infectious killer. The Lancet
• 11 Dec: Prevention Intention: Wafaa El-Sadr on People and Persistence in HIV Research. CSIS
• 11 Dec: Africa CDC and Zipline Partner to Advance Health System Responsiveness and Epidemic Preparedness Across Africa. Africa CDC
• 11 Dec: Global Leaders Announce Independent Coalition to Reimagine the Future of Development Cooperation. Future of Development Cooperation
• 12 Jan: After a year of chaos, US CDC’s global health work hangs in the balance. Devex
• 12 Jan: The America First Global Health Strategy and Pooled Procurement: What do we know about Existing Pooled Procurement Mechanisms?. KFF
• 13 Jan: Global Health: Down But Not Out. Geneva Health Files
• 13 Jan: Oxford University enters into licensing arrangement with Serum Institute of India to develop Rift Valley fever vaccine candidate. CEPI
• 13 Jan: US Congress backs Gavi, the Vaccine Alliance, despite Trump admin cuts. Devex
• 13 Jan: Devex Newswire: US Congress gives aid supporters $50B boost. Devex
• 13 Jan: China's Evolving Global Health Leadership. Think Global Health
• 13 Jan: US cuts to HIV programs in sub-Saharan Africa pose global risk, experts say. CIDRAP
• 13 Jan: CEPI announces funding for Rift Valley fever vaccine. CIDRAP
• 13 Jan: GARDP and Debiopharm Partner to Advance Development of Novel Gonorrhea Drug. AFP
• 13 Jan: Unitaid will provide funds for South Africa and Zambia to widen access to Gilead’s HIV prevention drug. STAT
• 14 Jan: Member States to Discuss US Withdrawal from WHO as Failure to Pay Fees Violates Agreement. Health Policy Watch
• 14 Jan: Inside Trump's $11 billion health plan to replace "neo-colonial" USAID. Axios
• 14 Jan: Gates Foundation unveils $9 billion budget and plans to cut staff. AP
• 14 Jan: Germany charts a new course for global aid. Devex
• 15 Jan: The Competing Objectives of the Bilateral American Global Health Agreements & the WHO Pathogen Access Benefits Sharing System. Geneva Health Files
• 15 Jan: Congressional Leaders Agree to $9.4 Billion in Global Health Spending – Countering Trump Proposal for Deeper Cuts. Health Policy Watch
• 15 Jan: Controversial US study on hepatitis B vaccines in Africa is cancelled. The Guardian
• 15 Jan: CDC Will Continue a Controversial Vaccine Study in Africa. Scientific American
• 15 Jan: U.S. Cuts Health Aid and Ties It to Funding Pledges by African Governments. The New York Times
• 15 Jan: The opportunity in the global health financing crisis. Nature
• 15 Jan: Rethinking Regulation for a Changing Africa: A Three-Part Reform Agenda. CGD
• 15 Jan: Making progress on global health will need high-quality evidence. Nature
• 15 Jan: One Year Post-USAID, Global Health Funding Stuck in Limbo. Think Global Health
• 16 Jan: Cloth wraps treated with ‘dirt cheap’ insecticide cut malaria cases in babies. The Guardian
• 16 Jan: Four paradigm shifts to shape an agenda for global health reforms. The Lancet
• 17 Dec: The Unfinished Agenda on Diversifying Vaccine Manufacturing: Six Takeaways from CGD Research. CGD
• 17 Jan: Research focus: the Fleming Initiative. The Lancet
• 17 Jan: The near death — and last-minute reprieve — of a trial for an HIV vaccine. NPR
• 18 Jan: African Scientists push homegrown health R&D solutions as global funding tightens. Business Day
• 18 Dec: Ants show new promise as a source of powerful antibiotics. News Medical
• 18 Dec: What We Know—and Don’t Know—About the Trump Administration’s Global Health Agreements. CGD
• 18 Dec: US–Africa bilateral health deals won’t help against diseases that ignore borders. Nature
• 18 Dec: The Kenya-US Health Agreement: The politics of health data demand scrutiny. University of Oslo
• 18 Dec: EU global health initiative still a mystery months after von der Leyen’s announcement. EuroActiv
• 18 Dec: Towards health sovereignty: partnerships to strengthen local production of medical products in Africa. The Lancet
• 19 Jan: Building authentic partnerships to overcome global health threats. BOND
• 19 Dec: I’m the former head of Pfizer R&D. I’m very worried about biopharma’s future. STAT
• 19 Dec: A Plasmodium-derived nanoparticle vaccine elicits sterile protection against malaria in mice. Nature
• 19 Dec: Experimental multistage malaria vaccine shows promising protection in small trial. CIDRAP
• 19 Dec: WHO, WIPO, WTO Symposium Examines Innovation Gaps, Access Inequities, and Supply Challenges in addressing AMR. WIPO
• 19 Dec: The year ahead: What’s next for financing for development and international financial architecture reform in 2026?. Global Policy Forum
• 21 Dec: WHO publishes new global analysis revealing major equity gaps in human genomics research. WHO
• 22 Dec: The Malaria Vaccine Deal That Could Save Millions — Here’s What to Know. Global Citizen
• 22 Dec: 30 Years of Standing for Science and Equity. AVAC
• 22 Dec: The vaccine cold chain: A fragile link in global health infrastructure. Open Access Government
• 22 Dec: Reducing antibiotic exposure to combat antimicrobial resistance: rethinking use, packaging, and dispensing practices. The Lancet
• 22 Dec: The America First Global Health Strategy and the Dilemma of Pan-Africanism. Global Policy
• 22 Dec: Five big global health wins in 2025 that will save millions of lives. The Guardian
• 22 Dec: Where did the Gates Foundation spend its money?. Devex
• 23 Dec: Equitable access to essential medicines to treat neglected tropical diseases: Latest developments from the World Health Organization. PLOS
• 23 Dec: Why NTDs are a prime investment for philanthropy. Devex
• 23 Dec: Why Is a 100-Year-Old Vaccine Still Our Only Defense Against the World’s Deadliest Infectious Disease?. Global Citizen
• 23 Dec: Meet Dr Happi. With $100m and a steely determination could he save the world from the next pandemic?. The Guardian
• 23 Dec: Japan to join Horizon Europe, strengthening EU role in global science. Science Business
• 24 Dec: US signs health agreements with African nations, warns against nonperformance. Reuters
• 24 Dec: How drug resistance undermines Africa's malaria milestones. TRT Afrika
• 24 Dec: WHO Finds Progress in Malaria Prevention Measures. Contagion Live
• 25 Dec: Integrating mobile laboratories into global health security: advancing collaboration through GOARN-DiSC. BMJ
• 26 Dec: 3 issues to watch in public health in 2026. STAT
• 26 Dec: Bridging the policy gap between climate change and antimicrobial resistance. The Lancet
• 28 Dec: How Cameroon Fought to Save Its Malaria Program After the U.S. Cut Critical Funding. The New York Times
• 28 Dec: 2025: A Brutal Year for Global Health. Health Policy Watch
• 29 Dec: America First Global Health Strategy: What the Kenya-US Agreement reveals about the new politics of global health assistance. LSE
• 29 Dec: The Guardian view on antibiotics: recent breakthroughs are great news, but humanity is losing the bigger race. The Guardian
• 29 Dec: Trump administration agrees to reconsider frozen and denied NIH grant submissions related to DEI. STAT
• 29 Dec: 4 more African nations secure $2.3bn US health funding under America First strategy. Business Insider Africa
• 30 Dec: More than half a million chikungunya cases reported globally in 2025. CIDRAP
• 30 Dec: The Trump Administration’s Most Paralyzing Blow to Science. The Atlantic
• 30 Dec: In a year of steep challenges, there were still shining moments in global health. NPR
• 31 Dec: Health advances marked 2025 as wars and funding cuts strained systems. UN News
• 31 Dec: Artificial intelligence unlocks new frontiers in RNA drug design. News Medical
Upcoming Meetings/ Webinars
--------------------------